Stryker Corp
SYK355.310USD
+1.220+0.34%
Cierre 12/15, 16:00（ET）Cotizaciones retrasadas 15 min
135.87BCap. mercado
46.12P/E TTM
Más Datos de Stryker Corp Compañía
Stryker Corporation is a medical technology company. The Company offers products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Its segments include MedSurg and Neurotechnology and Orthopaedics. Its MedSurg products include surgical equipment, patient and caregiver safety technologies, and navigation systems (Instruments), endoscopic and communications systems (Endoscopy), and patient handling, emergency medical equipment, intensive care disposable products and clinical communication and artificial intelligence-assisted virtual care platform technology (Medical). Neurotechnology includes neurosurgical, neurovascular and craniomaxillofacial implant products. Its Orthopaedics products primarily include implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. The Company also offers solutions for venous thromboembolism clot removal without the use of thrombolytic drugs.
Información de Stryker Corp
Símbolo de cotizaciónSYK
Nombre de la empresaStryker Corp
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoLobo (Kevin A)
Número de empleados53000
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 17
Dirección1941 Stryker Way
CiudadPORTAGE
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal49002
Teléfono12693852600
Sitio Webhttps://www.stryker.com/
Símbolo de cotizaciónSYK
Fecha de salida a bolsaMar 17, 1980
Director ejecutivoLobo (Kevin A)
Ejecutivos de Stryker Corp
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.90K
+1.24%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
12.69K
-3.79%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
8.15K
-21.45%
Mr. Preston W. Wells
Mr. Preston W. Wells
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
6.68K
-7.84%
Ms. Mary K. Brainerd
Ms. Mary K. Brainerd
Independent Director
Independent Director
6.38K
+9.63%
Mr. Rajeev Suri
Mr. Rajeev Suri
Independent Director
Independent Director
5.78K
+10.74%
Dr. Giovanni Caforio, M.D.
Dr. Giovanni Caforio, M.D.
Independent Director
Independent Director
2.80K
+25.01%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin A. Lobo
Mr. Kevin A. Lobo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
122.99K
+22.11%
Mr. Spencer S. Stiles
Mr. Spencer S. Stiles
President, Chief Operating Officer
President, Chief Operating Officer
64.47K
+13.09%
Ms. Ronda E. Stryker
Ms. Ronda E. Stryker
Independent Director
Independent Director
45.90K
+1.24%
Ms. Yin C. Becker
Ms. Yin C. Becker
Vice President - Chief Corporate Affairs Officer
Vice President - Chief Corporate Affairs Officer
33.06K
+2.71%
Mr. Viju S. Menon
Mr. Viju S. Menon
Group President - Global Quality and Operations
Group President - Global Quality and Operations
12.69K
-3.79%
Mr. Robert S. Fletcher
Mr. Robert S. Fletcher
Vice President, Chief Legal Officer
Vice President, Chief Legal Officer
8.15K
-21.45%
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Medical
990.00M
16.44%
Trauma and Extremities
957.00M
15.89%
Endoscopy
899.00M
14.93%
Instruments
768.00M
12.75%
Knees
640.00M
10.63%
Otro
1.77B
29.36%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
4.55B
75.62%
International
1.47B
24.38%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Medical
990.00M
16.44%
Trauma and Extremities
957.00M
15.89%
Endoscopy
899.00M
14.93%
Instruments
768.00M
12.75%
Knees
640.00M
10.63%
Otro
1.77B
29.36%
Estadísticas de accionistas
Actualizado: sáb., 16 de ago
Actualizado: sáb., 16 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
8.79%
Brown (John W)
5.24%
Greenleaf Trust
4.35%
BlackRock Institutional Trust Company, N.A.
4.25%
State Street Investment Management (US)
3.91%
Otro
73.45%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
8.79%
Brown (John W)
5.24%
Greenleaf Trust
4.35%
BlackRock Institutional Trust Company, N.A.
4.25%
State Street Investment Management (US)
3.91%
Otro
73.45%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
45.41%
Investment Advisor/Hedge Fund
21.89%
Bank and Trust
6.61%
Individual Investor
5.36%
Research Firm
3.31%
Pension Fund
2.04%
Sovereign Wealth Fund
1.31%
Hedge Fund
1.15%
Family Office
0.13%
Otro
12.79%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
3494
311.59M
81.48%
-5.78M
2025Q2
3464
329.22M
86.11%
-1.59M
2025Q1
3477
331.34M
86.70%
+478.07K
2024Q4
3392
326.31M
85.52%
-6.25M
2024Q3
3219
327.28M
85.85%
-2.63M
2024Q2
3172
322.05M
84.52%
-4.86M
2024Q1
3130
320.11M
84.03%
-8.55M
2023Q4
3047
327.61M
86.24%
+19.84M
2023Q3
2938
324.92M
85.54%
+14.80M
2023Q2
2898
325.04M
85.60%
+10.05M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
33.35M
8.72%
+437.93K
+1.33%
Jun 30, 2025
Brown (John W)
20.06M
5.25%
--
--
Feb 28, 2025
Greenleaf Trust
16.69M
4.37%
-427.58K
-2.50%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
16.08M
4.21%
-503.14K
-3.03%
Jun 30, 2025
State Street Investment Management (US)
14.96M
3.91%
+150.20K
+1.01%
Jun 30, 2025
T. Rowe Price Associates, Inc.
11.39M
2.98%
-237.74K
-2.05%
Jun 30, 2025
Geode Capital Management, L.L.C.
7.39M
1.93%
+79.65K
+1.09%
Jun 30, 2025
JP Morgan Asset Management
7.37M
1.93%
-98.87K
-1.32%
Jun 30, 2025
AllianceBernstein L.P.
5.60M
1.46%
+4.22M
+307.57%
Jun 30, 2025
Capital Research Global Investors
6.77M
1.77%
-98.16K
-1.43%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Jensen Quality Growth ETF
6.01%
iShares U.S. Medical Devices ETF
4.17%
AdvisorShares Focused Equity ETF
3.62%
Gabelli Growth Innovators ETF
3%
Global X Aging Population ETF
2.85%
Hennessy Sustainable ETF
2.77%
Knowledge Leaders Developed World ETF
2.73%
Health Care Select Sector SPDR Fund
2.51%
Proshares Ultra Health Care
2.42%
iShares U.S. Healthcare ETF
2.4%
Ver más
Jensen Quality Growth ETF
Proporción6.01%
iShares U.S. Medical Devices ETF
Proporción4.17%
AdvisorShares Focused Equity ETF
Proporción3.62%
Gabelli Growth Innovators ETF
Proporción3%
Global X Aging Population ETF
Proporción2.85%
Hennessy Sustainable ETF
Proporción2.77%
Knowledge Leaders Developed World ETF
Proporción2.73%
Health Care Select Sector SPDR Fund
Proporción2.51%
Proshares Ultra Health Care
Proporción2.42%
iShares U.S. Healthcare ETF
Proporción2.4%
Dividendos
Un total de
5.22B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Aug 07, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Oct 31, 2025 going ex on Sep 30, 2025
Sep 30, 2025
Oct 31, 2025
Sep 30, 2025
May 08, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Jul 31, 2025 going ex on Jun 30, 2025
Jun 30, 2025
Jul 31, 2025
Jun 30, 2025
Feb 05, 2025
SYK.NB Interim Cash Dividend of gross USD 0.84 paid on Apr 30, 2025 going ex on Mar 31, 2025
Mar 31, 2025
Apr 30, 2025
Mar 31, 2025
Dec 10, 2024
SYK.NB Final Cash Dividend of gross USD 0.84 paid on Jan 31, 2025 going ex on Dec 31, 2024
Dec 31, 2024
Jan 31, 2025
Dec 31, 2024
Aug 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Oct 31, 2024 going ex on Sep 30, 2024
Sep 30, 2024
Oct 31, 2024
Sep 30, 2024
May 09, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Jul 31, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 31, 2024
Jun 28, 2024
Feb 07, 2024
SYK.NB Interim Cash Dividend of gross USD 0.8 paid on Apr 30, 2024 going ex on Mar 27, 2024
Mar 29, 2024
Apr 30, 2024
Mar 27, 2024
Dec 05, 2023
SYK.NB Final Cash Dividend of gross USD 0.8 paid on Jan 31, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 31, 2024
Dec 28, 2023
Aug 02, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Oct 31, 2023 going ex on Sep 28, 2023
Sep 29, 2023
Oct 31, 2023
Sep 28, 2023
May 10, 2023
SYK.NB Interim Cash Dividend of gross USD 0.75 paid on Jul 31, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 31, 2023
Jun 29, 2023
Ver más
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Stryker Corp?
Los cinco principales accionistas de Stryker Corp son:
The Vanguard Group, Inc. posee 33.35M acciones, lo que representa el 8.72% del total de acciones.
Brown (John W) posee 20.06M acciones, lo que representa el 5.25% del total de acciones.
Greenleaf Trust posee 16.69M acciones, lo que representa el 4.37% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 16.08M acciones, lo que representa el 4.21% del total de acciones.
State Street Investment Management (US) posee 14.96M acciones, lo que representa el 3.91% del total de acciones.
The Vanguard Group, Inc. posee 33.35M acciones, lo que representa el 8.72% del total de acciones.
Brown (John W) posee 20.06M acciones, lo que representa el 5.25% del total de acciones.
Greenleaf Trust posee 16.69M acciones, lo que representa el 4.37% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 16.08M acciones, lo que representa el 4.21% del total de acciones.
State Street Investment Management (US) posee 14.96M acciones, lo que representa el 3.91% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Stryker Corp?
Los tres principales tipos de accionista de Stryker Corp son:
The Vanguard Group, Inc.
Brown (John W)
Greenleaf Trust
The Vanguard Group, Inc.
Brown (John W)
Greenleaf Trust
¿Cuántas instituciones poseen acciones de Stryker Corp (SYK)?
A fecha de 2025Q3, 3494 instituciones poseen acciones de Stryker Corp, con un valor de mercado combinado de aproximadamente 311.59M, lo que representa el 81.48% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -4.63%.
¿Cuál es la mayor fuente de ganancias de Stryker Corp?
El FY2025Q2, el segmento empresarial Medical generó la ganancia más alta para Stryker Corp, ascendiendo a 990.00M y representando el 16.44% de la ganancia total.
